| Patent Number |
Title Of Patent |
Date Issued |
| RE40811 |
Peripheralization of hematopoietic stem cells |
June 30, 2009 |
| The invention relates to in vivo peripheralization of CD34.sup.+ cells by administering anti-VLA-4 antibodies or anti-VCAM-1 antibodies. |
| 7094398 |
Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection an |
August 22, 2006 |
| The present invention provides for novel chimeric Ad-vectors carrying transgene, or portions of transgenes for stable and efficient gene transfer into diverse cell types or tissues in a CAR- and/or .alpha..sub..upsilon..beta..sub.3/5-independent manner. Also provided are methods for |
| 6184343 |
Fetal globin inducing factor |
February 6, 2001 |
| The invention is directed to fetal globin inducing factor (FGIF), and to nucleic acids encoding FGIF. FGIF controls the expression of fetal globin gene products. An FGIF polypeptide is shown in FIG. 3 and nucleotide sequences that encode FGIF polypeptides are shown in FIGS. 1 and 2. The |
| 5843438 |
Peripheralization of hematopoietic stem cells |
December 1, 1998 |
| The invention relates to in vivo peripheralization of CD34.sup.+ cells by administering anti-VLA-4 antibodies or anti-VCAM-1 antibodies. |
| 5824304 |
Peripheralization of hematopoietic stem cells |
October 20, 1998 |
| The invention provides methods for peripheralizing CD34.sup.+ cells, including hematopoietic stem cells. In a first aspect, the method comprises the step of administering a blocking agent of VLA-4 antigen on the surface of CD34.sup.+ cells. In a second aspect, the method comprises ad |
| 5695755 |
Peripheralization of hematopoietic stem cells |
December 9, 1997 |
| The invention provides methods for peripheralizing CD 34.sup.+ cells, including hematopoietic stem cells. In a first aspect, the method comprises the step of administering a blocking agent of VLA-4 antigen on the surface of CD34.sup.+ cells. In a second aspect, the method comprises a |
